Financhill
Back

Protara Therapeutics Quote, Financials, Valuation and Earnings

Buy
52

TARA
Protara Therapeutics

Last Price:
2.93
Seasonality Move:
-1.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Protara Therapeutics Price Quote

$2.93
-0.06 (-2.01%)
(Updated: May 21, 2024 at 6:20 PM ET)

Protara Therapeutics Key Stats

Buy
52
Protara Therapeutics (TARA) is a Buy

Day range:
$2.84 - $3.17
52-week range:
$1.04 - $5.24
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.05%

Volume:
358.7K
Avg. volume:
398.5K
1-year change:
-2.92%
Market cap:
$61.6M
Revenue:
$0
EPS:
$-3.74

How Much Does Protara Therapeutics Make?

Data Unavailable

Is Protara Therapeutics Growing As A Company?

Data Unavailable

Protara Therapeutics Stock Price Performance

What Is Protara Therapeutics 52-Week High & Low?

Protara Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Protara Therapeutics?

Is Protara Therapeutics Cash Flow Positive?

  • What Is TARA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$35M
  • What Is Protara Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$103K
  • What Is Protara Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $66.3M

Protara Therapeutics Return On Invested Capital

Data Unavailable

Protara Therapeutics Earnings Date & Stock Price

Protara Therapeutics Competitors

Protara Therapeutics Dividend Yield

Data Unavailable

Protara Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.44%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 27.80
Upside from Last Price: 829.77%

Major Shareholders

  • How many TARA shares are owned by institutional investors?
    8.7M TARA shares are owned by institutional investors
  • How many TARA shares are owned by insiders?
    1.6M TARA shares are owned by insiders